Kemwell Biopharma has signed an agreement with a European company for the development and manufacture of monoclonal antibody therapeutics. Kemwell will provide technology transfer, process industrialization, scale-up, manufacturing of toxicology materials, cGMP manufacturing of clinical materials and commercial manufacturing for both drug substance and fill/finish in vials from Kemwell’s new facility in Bangalore, India. Kemwell’s managing director, Anurag Bagaria, remarked, “This broad develop...